PSBD

PSBD is an externally managed BDC that lends to private U.S. companies via covenant-lite corporate loans and, notably, the equity and junior debt tranches of CLOs — the riskiest, most loss-absorbing slices of structured credit. The MD&A confirms the portfolio 'may be deemed Covenant-Lite Loans' with 'fewer or no maintenance covenants,' which removes a key lender protection precisely when it matters most. The value case is real: stockholders' equity of $464M over 31.2M shares implies a NAV near $14.87, so at $10.46 the stock trades around 0.70x book. Management is leaning into that gap, with share repurchases up over 13x to $18.0M — buying below NAV is accretive to remaining holders, and operating cash flow of $161M (up 180%) shows the loan book is still throwing off cash to fund it.

But the discount exists for reasons the numbers make plain. FY2025 net income swung to -$3.17M (from +$47.7M and +$108M in the two prior years), and the swing history — +$19M, -$74.5M, +$108M, +$47.7M, -$3.17M — shows earnings that are dominated by mark-to-market on the credit book, not steady net investment income. Total assets shrank 14.8% and equity 13.7%, so the book is contracting, and accumulated deficit worsened to -$130M (down another 76.7%), signaling distributions and/or realized losses running ahead of earnings and eroding NAV since the January 2024 IPO at $16.45. Shareholders are already down sharply from that offering price.